Filed: 11/14/2024ACC: 0001104659-24-118335
📋 What this filing means
AVORO CAPITAL ADVISORS LLC filed this quarterly 13F‑HR report disclosing 36 equity positions with a total reported market value of $6.86B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
36
Positions
$6.86B
Total AUM (reported)
178.44M
Total Shares
Allocation by class
COMMON$5.26B76.7%
SPONSORED ADR$1.46B21.3%
CLASS A ORD$139.67M2.0%
Portfolio Concentration
Top 3$2.44B35.6%
4–10$2.33B34.0%
11–25$1.81B26.4%
Rest$273.19M4.0%
Top 3 weight
35.6%
Top 10 weight
69.6%
Voting Authority Distribution
Total shares with voting rights: 178.44M
Sole
Full voting authority
178.44M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole36
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings36
Rows:
UNITED THERAPEUTICS CORP
SOLEShares2.86M
TypeSH
Market value$1.02B
14.94%
Sole
2.86M
Shared
0.00
None
0.00
ASCENDIS PHARMA
SOLEShares4.99M
TypeSH
Market value$744.89M
10.86%
Sole
4.99M
Shared
0.00
None
0.00
ARGENX SE
SOLEShares1.24M
TypeSH
Market value$671.35M
9.79%
Sole
1.24M
Shared
0.00
None
0.00
KRYSTAL BIOTECH INC
SOLEShares2.62M
TypeSH
Market value$477.32M
6.96%
Sole
2.62M
Shared
0.00
None
0.00
MADRIGAL PHARMACEUTICALS INC
SOLEShares2.03M
TypeSH
Market value$430.59M
6.28%
Sole
2.03M
Shared
0.00
None
0.00
APELLIS PHARMACEUTICALS INC.
SOLEShares11.11M
TypeSH
Market value$320.44M
4.67%
Sole
11.11M
Shared
0.00
None
0.00
SAREPTA THERAPEUTICS INC
SOLEShares2.56M
TypeSH
Market value$319.16M
4.65%
Sole
2.56M
Shared
0.00
None
0.00
AVIDITY BIOSCIENCES INC
SOLEShares6.88M
TypeSH
Market value$315.77M
4.60%
Sole
6.88M
Shared
0.00
None
0.00
AMICUS THERAPEUTICS INC.
SOLEShares23.18M
TypeSH
Market value$247.51M
3.61%
Sole
23.18M
Shared
0.00
None
0.00
INTRA-CELLULAR THERAPIES INC
SOLEShares3.05M
TypeSH
Market value$223.17M
3.25%
Sole
3.05M
Shared
0.00
None
0.00
XENON PHARMACEUTICALS INC
SOLEShares5.67M
TypeSH
Market value$223.10M
3.25%
Sole
5.67M
Shared
0.00
None
0.00
KYMERA THERAPEUTICS INC
SOLEShares4.50M
TypeSH
Market value$212.99M
3.11%
Sole
4.50M
Shared
0.00
None
0.00
VERA THERAPEUTICS INC
SOLEShares4.31M
TypeSH
Market value$190.48M
2.78%
Sole
4.31M
Shared
0.00
None
0.00
ARROWHEAD PHARMACEUTICALS INC.
SOLEShares8.89M
TypeSH
Market value$172.18M
2.51%
Sole
8.89M
Shared
0.00
None
0.00
BIOMARIN PHARMACEUTICAL INC
SOLEShares2.04M
TypeSH
Market value$143.25M
2.09%
Sole
2.04M
Shared
0.00
None
0.00
MOONLAKE IMMUNOTHERAPEUTICS
SOLEShares2.77M
TypeSH
Market value$139.67M
2.04%
Sole
2.77M
Shared
0.00
None
0.00
VAXCYTE INC
SOLEShares1.18M
TypeSH
Market value$134.27M
1.96%
Sole
1.18M
Shared
0.00
None
0.00
SOLENO THERAPEUTICS INC
SOLEShares2.18M
TypeSH
Market value$110.12M
1.61%
Sole
2.18M
Shared
0.00
None
0.00
BIOCRYST PHARMACEUTICALS INC
SOLEShares11.87M
TypeSH
Market value$90.17M
1.31%
Sole
11.87M
Shared
0.00
None
0.00
SYNDAX PHARMACEUTICALS INC
SOLEShares3.89M
TypeSH
Market value$74.85M
1.09%
Sole
3.89M
Shared
0.00
None
0.00
OCULAR THERAPEUTIX INC
SOLEShares8.06M
TypeSH
Market value$70.12M
1.02%
Sole
8.06M
Shared
0.00
None
0.00
KURA ONCOLOGY INC
SOLEShares3.54M
TypeSH
Market value$69.20M
1.01%
Sole
3.54M
Shared
0.00
None
0.00
MERUS N V
SOLEShares1.35M
TypeSH
Market value$67.70M
0.99%
Sole
1.35M
Shared
0.00
None
0.00
TOURMALINE BIO INC
SOLEShares2.22M
TypeSH
Market value$57.13M
0.83%
Sole
2.22M
Shared
0.00
None
0.00
MANNKIND CORP
SOLEShares8.75M
TypeSH
Market value$55.04M
0.80%
Sole
8.75M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
UNITED THERAPEUTICS CORPSOLE | Common | 2.86M | SH | $1.02B 14.94% | 2.86M | 0.00 | 0.00 |
ASCENDIS PHARMASOLE | Sponsored ADR | 4.99M | SH | $744.89M 10.86% | 4.99M | 0.00 | 0.00 |
ARGENX SESOLE | Sponsored ADR | 1.24M | SH | $671.35M 9.79% | 1.24M | 0.00 | 0.00 |
KRYSTAL BIOTECH INCSOLE | Common | 2.62M | SH | $477.32M 6.96% | 2.62M | 0.00 | 0.00 |
MADRIGAL PHARMACEUTICALS INCSOLE | Common | 2.03M | SH | $430.59M 6.28% | 2.03M | 0.00 | 0.00 |
APELLIS PHARMACEUTICALS INC.SOLE | Common | 11.11M | SH | $320.44M 4.67% | 11.11M | 0.00 | 0.00 |
SAREPTA THERAPEUTICS INCSOLE | Common | 2.56M | SH | $319.16M 4.65% | 2.56M | 0.00 | 0.00 |
AVIDITY BIOSCIENCES INCSOLE | Common | 6.88M | SH | $315.77M 4.60% | 6.88M | 0.00 | 0.00 |
AMICUS THERAPEUTICS INC.SOLE | Common | 23.18M | SH | $247.51M 3.61% | 23.18M | 0.00 | 0.00 |
INTRA-CELLULAR THERAPIES INCSOLE | Common | 3.05M | SH | $223.17M 3.25% | 3.05M | 0.00 | 0.00 |
XENON PHARMACEUTICALS INCSOLE | Common | 5.67M | SH | $223.10M 3.25% | 5.67M | 0.00 | 0.00 |
KYMERA THERAPEUTICS INCSOLE | Common | 4.50M | SH | $212.99M 3.11% | 4.50M | 0.00 | 0.00 |
VERA THERAPEUTICS INCSOLE | Common | 4.31M | SH | $190.48M 2.78% | 4.31M | 0.00 | 0.00 |
ARROWHEAD PHARMACEUTICALS INC.SOLE | Common | 8.89M | SH | $172.18M 2.51% | 8.89M | 0.00 | 0.00 |
BIOMARIN PHARMACEUTICAL INCSOLE | Common | 2.04M | SH | $143.25M 2.09% | 2.04M | 0.00 | 0.00 |
MOONLAKE IMMUNOTHERAPEUTICSSOLE | CLASS A ORD | 2.77M | SH | $139.67M 2.04% | 2.77M | 0.00 | 0.00 |
VAXCYTE INCSOLE | Common | 1.18M | SH | $134.27M 1.96% | 1.18M | 0.00 | 0.00 |
SOLENO THERAPEUTICS INCSOLE | Common | 2.18M | SH | $110.12M 1.61% | 2.18M | 0.00 | 0.00 |
BIOCRYST PHARMACEUTICALS INCSOLE | Common | 11.87M | SH | $90.17M 1.31% | 11.87M | 0.00 | 0.00 |
SYNDAX PHARMACEUTICALS INCSOLE | Common | 3.89M | SH | $74.85M 1.09% | 3.89M | 0.00 | 0.00 |
OCULAR THERAPEUTIX INCSOLE | Common | 8.06M | SH | $70.12M 1.02% | 8.06M | 0.00 | 0.00 |
KURA ONCOLOGY INCSOLE | Common | 3.54M | SH | $69.20M 1.01% | 3.54M | 0.00 | 0.00 |
MERUS N VSOLE | Common | 1.35M | SH | $67.70M 0.99% | 1.35M | 0.00 | 0.00 |
TOURMALINE BIO INCSOLE | Common | 2.22M | SH | $57.13M 0.83% | 2.22M | 0.00 | 0.00 |
MANNKIND CORPSOLE | Common | 8.75M | SH | $55.04M 0.80% | 8.75M | 0.00 | 0.00 |
Page 1 of 2